A fluorinated glucose analog, 2-fluoro-2-deoxy-D-glucose (F-18): nontoxic tracer for rapid tumor detection
about
Noninvasive imaging modalities to visualize atherosclerotic plaquesApplications of 2-deoxy-2-fluoro-D-glucose (FDG) in Plant Imaging: Past, Present, and FutureCancer Metabolism: A Modeling PerspectiveMonitoring of anti-cancer treatment with (18)F-FDG and (18)F-FLT PET: a comprehensive review of pre-clinical studiesThe sweet spot: FDG and other 2-carbon glucose analogs for multi-modal metabolic imaging of tumor metabolism18-Fluorodeoxyglucose positron emission tomography (FDG-PET) and the staging of early lung cancerChemical Approach to Positional Isomers of Glucose-Platinum Conjugates Reveals Specific Cancer Targeting through Glucose-Transporter-Mediated Uptake in Vitro and in VivoDawn of advanced molecular medicine: nanotechnological advancements in cancer imaging and therapy.Visualizing sweetness: increasingly diverse applications for fluorescent-tagged glucose bioprobes and their recent structural modificationsCase report: PET/CT, a cautionary taleLongitudinal optical imaging of tumor metabolism and hemodynamicsPET/CT in Oncology: Current Status and Perspectives.High Expression of Aldolase B Confers a Poor Prognosis for Rectal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy.Pre-clinical evaluation of fluorescent deoxyglucose as a topical contrast agent for the detection of Barrett's-associated neoplasia during confocal imaging.Anticancer targets in the glycolytic metabolism of tumors: a comprehensive reviewEscherichia coli expressing EAST1 toxin did not cause an increase of cAMP or cGMP levels in cells, and no diarrhea in 5-day old gnotobiotic pigs.Current concepts of metastasis in melanoma.Differential uptake of (18)F-fluorodeoxyglucose by experimental tumors xenografted into immunocompetent and immunodeficient mice and the effect of immunomodification.Metabolic positron emission tomography imaging in cancer detection and therapy response.Imaging of treatment response to the combination of carboplatin and paclitaxel in human ovarian cancer xenograft tumors in mice using FDG and FLT PETOptimum lean body formulation for correction of standardized uptake value in PET imagingAdvances in paediatric tumour imaging.Multimodal image coregistration and inducible selective cell ablation to evaluate imaging ligandsDefining key signaling nodes and therapeutic biomarkers in NF1-mutant cancers.Positron emission tomography scanning is not superior to whole body multidetector helical computed tomography in the preoperative staging of colorectal cancer.Review of functional/anatomical imaging in oncology.Modeling cancer metabolism on a genome scale.Update of PET and PET/CT for hepatobiliary and pancreatic malignancies.2-NBDG fluorescence imaging of hypermetabolic circulating tumor cells in mouse xenograft model of breast cancerThe radiation burden of radiological investigationsDesigning polymers with sugar-based advantages for bioactive delivery applicationsThe Emerging Hallmarks of Cancer MetabolismGallium-68-labeled DOTA-rhenium-cyclized alpha-melanocyte-stimulating hormone analog for imaging of malignant melanoma.Variance of SUVs for FDG-PET/CT is greater in clinical practice than under ideal study settingsIs PET-CT an accurate method for the differential diagnosis between chondroma and chondrosarcoma?FDG-PET for evaluating the antitumor effect of intraarterial 3-bromopyruvate administration in a rabbit VX2 liver tumor modelHyaluronic acid-serum hydrogels rapidly restore metabolism of encapsulated stem cells and promote engraftment.Pharmacodynamic markers for choline kinase down-regulation in breast cancer cells.Chemical approaches to perturb, profile, and perceive glycans.Positron Emission Tomography (PET) radiotracers in oncology--utility of 18F-Fluoro-deoxy-glucose (FDG)-PET in the management of patients with non-small-cell lung cancer (NSCLC).
P2860
Q26738579-F08D89A9-C8DD-4684-95B5-6AF2DE1601F0Q26744615-7789AA16-DD3A-44C4-BDCB-F6D5EBD11FD9Q26770819-061ECBCA-76AC-49DA-BF2E-602EF47AFC96Q26778463-CE242F96-0073-4F2F-812D-04CFA4E7B579Q26999434-30768D7D-3087-4441-8A4C-7485A2DC4307Q28346531-D0EA0BEF-9CA0-4806-A7D8-931007AF2375Q28828412-85B85124-375A-47FB-9267-99DA98E4F66DQ30421668-E00FB11E-0B9B-46C0-9E33-0A743E0D9373Q30426543-FBA42E70-9AB3-45D3-A033-D70A2A70E493Q33293417-66D72B29-70F6-434B-A1CD-3AE5D73F8DFFQ33632108-1C327EB2-BE04-4AE8-8174-864652552806Q33665109-84A958CC-E2A1-4F29-8A74-8A22CE1E8E9BQ33776709-2C0DDF45-F174-4CC1-972B-2EF76C667B58Q34011842-11CCEF97-80FA-49E9-962A-3A6CBB480B85Q34028478-6B6D90B9-9A2C-4253-8C85-3FF7A435352BQ34294931-555836B2-C875-43AB-BB95-30F36815B38EQ34610427-FC837C50-F162-4861-85B1-A11CA7802880Q34771664-C915958C-B7C1-4F75-BD42-B97CA8047858Q34786518-EE55EC09-CA5B-48AD-A667-DD6F5AE43A18Q35081130-5865322A-4677-4CC0-98CC-66CECEC8D095Q35111964-C6A5459C-08CD-4950-9C3B-AA1BA44478FBQ35283700-E53680C4-E739-4782-9746-82B05F83809BQ35651214-F7A68992-7F96-41FC-99F4-695316FF66EBQ35657827-EE7CD126-C880-4E47-BD24-7E70A7365008Q35760705-9F52A534-1B45-40BD-ACE5-4949E832C201Q35809612-1849DD76-080F-4BDA-B4E6-4C10FA48A73AQ35850350-D205FBF5-17DB-4CF0-A278-B66AE48B42DFQ36066047-7410A046-4ADC-4928-91F8-F8166E0917F9Q36119176-102CD26B-9560-4402-AFAA-C3289AED4F4AQ36121517-38EE458E-DA13-4911-A021-93D6B47300C7Q36307576-6006ACB9-746E-4551-8F25-5D4E1CF061CBQ36468964-F2DA8203-6AA0-4C4F-A6FC-EF510CC44333Q36580750-781DB778-9097-4AF9-9DCB-0B5EFDF85B7DQ36626050-65D35D50-813F-435F-84ED-15DA5759AEA8Q36632352-A648E415-3FE9-4C86-955E-414CA0B4F8C9Q37063643-4976C563-EB7C-4CB3-AF0C-0E525ABD43B4Q37165628-FA9F8B3B-107B-4FF2-B1F6-47E69D0DC5D6Q37165855-85F815EC-16FA-45B0-941D-ED788226A266Q37229796-E5AA5EDF-6CC9-4D14-BCC9-7ABC245D1EACQ37301288-22E3E8D0-2903-4D35-B9E0-2FD6B00F56BA
P2860
A fluorinated glucose analog, 2-fluoro-2-deoxy-D-glucose (F-18): nontoxic tracer for rapid tumor detection
description
1980 nî lūn-bûn
@nan
1980 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1980 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1980年の論文
@ja
1980年論文
@yue
1980年論文
@zh-hant
1980年論文
@zh-hk
1980年論文
@zh-mo
1980年論文
@zh-tw
1980年论文
@wuu
name
A fluorinated glucose analog, ...... acer for rapid tumor detection
@ast
A fluorinated glucose analog, ...... acer for rapid tumor detection
@en
A fluorinated glucose analog, ...... acer for rapid tumor detection
@nl
type
label
A fluorinated glucose analog, ...... acer for rapid tumor detection
@ast
A fluorinated glucose analog, ...... acer for rapid tumor detection
@en
A fluorinated glucose analog, ...... acer for rapid tumor detection
@nl
prefLabel
A fluorinated glucose analog, ...... acer for rapid tumor detection
@ast
A fluorinated glucose analog, ...... acer for rapid tumor detection
@en
A fluorinated glucose analog, ...... acer for rapid tumor detection
@nl
P2093
P3181
P1476
A fluorinated glucose analog, ...... acer for rapid tumor detection
@en
P2093
D Bandoypadhyay
D F Sacker
H L Atkins
J S Fowler
P3181
P356
10.1097/00004728-198012000-00045
P407
P577
1980-07-01T00:00:00Z